Denver, Colorado and Orlando, Florida (PRWEB) June 07, 2012
Intelerad® Medical Systems, a leader in medical imaging PACS, RIS and workflow solutions, today announced at SIIM 2012 the support for Tomosynthesis in the IntelePACS® Breast Imaging module.
The Intelerad Breast Imaging™ module offers a universal worklist that eliminates the need for dedicated workstations and gives access to multi-modality images regardless of where radiologists read from, with option to integrate with a breast imaging, reporting and data system (BIRADS).
“Intelerad’s new Tomosynthesis module seamlessly adds new modality capabilities into the existing mammography workflow and viewing environment, with no additional capital investment for new workstations” says Rick Rubin, Chief Engineering Officer at Intelerad. “While other vendors require dedicated workstations or different workflows, Intelerad can support the new tomosynthesis modality seamlessly, enhancing and extending the Breast Imaging™ unified worklist and workflow optimization.”
Intelerad’s Breast Imaging™ module with Tomosynthesis Support enables more accurate and earlier cancer detection within existing workflows, improving the patient experience through less recalls and associated anxiety, helping referring physicians put patient care first.
Intelerad is a member of the National Breast Centers Consortium.
Intelerad is exhibiting at SIIM, booth number 417.
###
About Intelerad
Intelerad Medical Systems is a leader in distributed radiology, specializing in RIS, PACS and workflow solutions for healthcare organizations. Intelerad solutions increase productivity and streamline workflow by overcoming technical barriers in distributed and complex environments. Highly scalable, flexible and robust, Intelerad’s solutions offer high performance and industry leading customer service and support. Intelerad solutions like KLAS category leader IntelePACS® and Frost & Sullivan Healthcare Innovation Award recipient InteleOne® are used in more than 800 sites across North America, Oceania and the United Kingdom.